Mortality in Emergency Department Sepsis (MEDS) score predicts 1-year mortality

被引:75
作者
Shapiro, Nathan I. [1 ]
Howell, Michael D.
Talmor, Daniel
Donnino, Michael
Ngo, Long
Bates, David W.
机构
[1] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm & Crit Care, Boston, MA 02215 USA
[3] Beth Israel Deaconess Med Ctr, Dept Gen Internal Med, Boston, MA 02215 USA
[4] Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
[6] Brigham & Womens Hosp, Div Internal Med, Boston, MA 02115 USA
关键词
sepsis; infection; mortality; risk stratification; severity of illness;
D O I
10.1097/01.CCM.0000251508.12555.3E
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. To assess the predictive performance for 1-yr mortality of the previously derived and validated Mortality in Emergency Department Sepsis (MEDS) score. Design. Prospective cohort study. Patients: Consecutive adult (aged >= 18 yrs) emergency department patients presenting to an urban, tertiary care, university hospital were eligible if they had a clinically suspected infection as indicated by the decision to obtain a blood culture. The enrollment period was between February 1, 2000, and February 1, 2001. Of 3,926 eligible patient visits, 3,762 (96%) were enrolled and 3,102 unique first visits were analyzed. Interventions, None. Measurements and Main Results., A total of 667 patients (21.5%) died within 1 yr. The unadjusted 1-yr mortality rates for the MEDS risk groups were: very low risk, 7%; low risk, 20%; moderate risk, 37%; high risk, 64%; very high risk, 80%. Using a Cox proportional hazard model that controlled for age, sex, and Charlson co-morbidity index, the 1-yr hazard ratios compared with the baseline very low-risk group were: low risk, 2.2 (1.7-2.9); moderate risk, 3.5 (2.7-4.6); high risk, 6.7 (4.9-9.3); and very high risk, 10.5 (7.2-15.4). The groups were significantly different (p <.0001). Conclusions: Although the score was initially derived for 28-day in-hospital mortality, our results indicate that the MEDS score also predicts patient survival at 1 yr after index hospital visit with suspected infection. The score needs external validation before widespread use.
引用
收藏
页码:192 / 198
页数:7
相关论文
共 34 条
[1]   Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].
Abraham, E ;
Laterre, P ;
Garg, R ;
Levy, H ;
Talwar, D ;
Trzaskoma, BL ;
Francois, B ;
Guy, JS ;
Bruckmann, M ;
Rea-Neto, A ;
Rossaint, R ;
Perrotin, D ;
Sablotzki, A ;
Arkins, N ;
Utterback, BG ;
Macias, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341
[2]   Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study [J].
Alberti, C ;
Brun-Buisson, C ;
Burchardi, H ;
Martin, C ;
Goodman, S ;
Artigas, A ;
Sicignano, A ;
Palazzo, M ;
Moreno, R ;
Boulmé, R ;
Lepage, E ;
Le Gall, JR .
INTENSIVE CARE MEDICINE, 2002, 28 (02) :108-121
[3]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[4]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[5]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[6]   EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units [J].
Brun-Buisson, C ;
Meshaka, P ;
Pinton, P ;
Vallet, B ;
Rodie-Talbere, P ;
Zahar, JR .
INTENSIVE CARE MEDICINE, 2004, 30 (04) :580-588
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]   New strategies for clinical trials in patients with sepsis and septic shock [J].
Cohen, J ;
Guyatt, G ;
Bernard, GR ;
Calandra, T ;
Cook, D ;
Elbourne, D ;
Marshall, J ;
Nunn, A ;
Opal, S .
CRITICAL CARE MEDICINE, 2001, 29 (04) :880-886
[9]   DETERMINANTS IN CANADIAN HEALTH-CARE WORKERS OF THE DECISION TO WITHDRAW LIFE-SUPPORT FROM THE CRITICALLY ILL [J].
COOK, DJ ;
GUYATT, GH ;
JAESCHKE, R ;
REEVE, J ;
SPANIER, A ;
KING, D ;
MOLLOY, DW ;
WILLAN, A ;
STREINER, DL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (09) :703-708
[10]   Risk and the efficacy of antiinflammatory agents - Retrospective and confirmatory studies of sepsis [J].
Eichacker, PQ ;
Parent, C ;
Kalil, A ;
Esposito, C ;
Cui, X ;
Banks, SM ;
Gerstenberger, EP ;
Fitz, Y ;
Danner, RL ;
Natanson, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (09) :1197-1205